KRAS and lung cancer: Recently, lipid nanoparticles carrying KRAS siRNAs reduced its expression in several lung cancer cell lines, including human (A549 and H441) and mouse (CMT-167 and Lacun3) cells, and proliferation was observed through colony-forming assays [158].